A detailed history of Goldman Sachs Group Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,717,457 shares of TAK stock, worth $51.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,717,457
Previous 4,209,431 11.69%
Holding current value
$51.5 Million
Previous $58.5 Million 17.73%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$12.6 - $13.67 $6.2 Million - $6.73 Million
-491,974 Reduced 11.69%
3,717,457 $48.1 Million
Q1 2024

May 15, 2024

SELL
$13.89 - $15.04 $1.29 Million - $1.4 Million
-93,131 Reduced 2.16%
4,209,431 $58.5 Million
Q4 2023

Feb 13, 2024

SELL
$13.36 - $15.43 $7.31 Million - $8.44 Million
-547,250 Reduced 11.28%
4,302,562 $61.4 Million
Q3 2023

May 14, 2024

BUY
$15.03 - $16.32 $8.23 Million - $8.93 Million
547,250 Added 12.72%
4,849,812 $75 Million
Q3 2023

Nov 14, 2023

BUY
$15.03 - $16.32 $1.77 Million - $1.93 Million
118,088 Added 2.5%
4,849,812 $75 Million
Q2 2023

May 14, 2024

BUY
$15.57 - $17.11 $5.92 Million - $6.51 Million
380,221 Added 8.74%
4,731,724 $74.3 Million
Q2 2023

Aug 14, 2023

BUY
$15.57 - $17.11 $5.92 Million - $6.51 Million
380,221 Added 8.74%
4,731,724 $74.3 Million
Q1 2023

May 14, 2024

BUY
$15.28 - $16.48 $6.07 Million - $6.54 Million
396,999 Added 10.04%
4,351,503 $71.7 Million
Q1 2023

May 11, 2023

BUY
$15.28 - $16.48 $6.07 Million - $6.54 Million
396,999 Added 10.04%
4,351,503 $71.7 Million
Q4 2022

May 14, 2024

SELL
$12.42 - $15.62 $3.95 Million - $4.97 Million
-317,965 Reduced 7.44%
3,954,504 $61.7 Million
Q4 2022

Feb 13, 2023

SELL
$12.42 - $15.62 $3.95 Million - $4.97 Million
-317,965 Reduced 7.44%
3,954,504 $61.7 Million
Q3 2022

May 14, 2024

BUY
$12.8 - $28.65 $8.16 Million - $18.3 Million
637,688 Added 17.54%
4,272,469 $55.4 Million
Q3 2022

Nov 10, 2022

BUY
$12.8 - $28.65 $8.16 Million - $18.3 Million
637,688 Added 17.54%
4,272,469 $55.4 Million
Q2 2022

May 14, 2024

SELL
$13.12 - $15.03 $8.76 Million - $10 Million
-667,781 Reduced 15.52%
3,634,781 $51 Million
Q2 2022

Aug 15, 2022

SELL
$13.12 - $15.03 $7.98 Million - $9.14 Million
-607,908 Reduced 14.33%
3,634,781 $51 Million
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $6.9 Million - $7.83 Million
509,886 Added 13.66%
4,242,689 $60.8 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $15.8 Million - $19.7 Million
1,198,284 Added 47.28%
3,732,803 $50.9 Million
Q3 2021

Nov 10, 2021

BUY
$16.3 - $17.26 $41.3 Million - $43.7 Million
2,534,519 New
2,534,519 $41.5 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.